Cargando…
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
The global pandemic of coronavirus disease 2019 (COVID‐19) is associated with the development of acute respiratory distress syndrome (ARDS), which requires ventilation in critically ill patients. The pathophysiology of ARDS results from acute inflammation within the alveolar space and prevention of...
Autores principales: | Whyte, Claire S., Morrow, Gael B., Mitchell, Joanne L., Chowdary, Pratima, Mutch, Nicola J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264738/ https://www.ncbi.nlm.nih.gov/pubmed/32329246 http://dx.doi.org/10.1111/jth.14872 |
Ejemplares similares
-
Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi
por: Narwal, Anuj, et al.
Publicado: (2023) -
The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
por: Whyte, Claire S., et al.
Publicado: (2022) -
Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation
por: Morrow, Gael B., et al.
Publicado: (2019) -
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease
por: Morrow, Gael B., et al.
Publicado: (2021) -
Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation
por: Alshehri, Fahad S. M., et al.
Publicado: (2021)